In This Section

Hannah-Lise Tirado Schofield, PhD, ABPP-CN
Hannah-Lise Tirado Schofield
Neuropsychologist

Dr. Schofield's research focuses on neurocognitive outcomes of oncology treatment. Her areas of interest are acute and long-term neurotoxicities and cognitive sequelae of cellular therapy, including hematopoietic stem cell transplant and chimeric antigen receptor (CAR) T-cell therapy.

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

Education and Training

BA, Mount Holyoke College (Psychology, Studio Art), 2001

MS, Pennsylvania State University (Psychology), 2005

PhD, Pennsylvania State University (Psychology), 2009

Psychology Internship, Allegheny General Hospital (Clinical Psychology), 2009

Postdoctoral Fellowship, Allegheny General Hospital (Clinical Neuropsychology), 2011

Board Certifications

Clinical Neuropsychology, American Board of Professional Psychology, 2014

Pediatric Neuropsychology, American Board of Professional Psychology, 2019

Titles and Academic Titles

Neuropsychologist

Assistant Professor of Clinical Neuropsychology, University of Pennsylvania

Professional Memberships

Children’s Oncology Group, 2018-

American Academy of Clinical Neuropsychology, 2014-

American Board of Professional Psychology (Clinical Neuropsychology), 2017-

International Neuropsychology Society, 2009-

Publication Highlights

Phillips NS, Duke ES, Schofield HT, Ullrich NJ. Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact. J Clin Oncol. 2021 Apr; JCO2002533. doi: 10.1200/JCO.20.02533. Epub ahead of print. PMID: 33886374
Mack A, Schofield, HL. Applying (or not?) CAR-T Neurotoxicity Experience to COVID19 Delirium and Agitation. Psychosomatics. 2020 Apr; S0033-3182(20)30131-6. PubMed PMID: 32739050
Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE. Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant. 2018 May; 53(5):535-555. doi: 10.1038/s41409-017-0055-7. Epub 2018 Jan 17. Review. PMID: 29343837

Links of Interest